Anne-Sophie Villégier

Dr. Anne-Sophie Villégier

INSTITUT NATIONAL DE L'ENVIRONNEMENT INDUSTRIEL ET DES RISQUES

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2012 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
RHRania Harati
Rania Harati
AVAnne-Sophie Villégier
Anne-Sophie Villégier
William BanksWilliam Banks
William Banks
AMAloïse Mabondzo
Aloïse Mabondzo
Background: P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) play a critical role in keeping neurotoxic substances from entering the brain. We and others have previously reported an impact of inflammation on the regulation of adult blood–brain barrier (BBB) efflux transporters. However, studies in children have not been done. From the pediatric clinical perspective, it is important to understand how the central nervous system (CNS) and BBB drug efflux transporters differ in childhood from those of adults under normal and inflammatory conditions. Therefore, we examined and compared the regulation of P-gp and BCRP expression and transport activity in young and adult BBB and investigated the molecular mechanisms underlying inflammatory responses.Methods: Rats at postnatal day (P) P21 and P84, corresponding to the juvenile and adult stages of human brain maturation, respectively, were treated with endothelin-1 (ET-1) given by the intracerebroventricular (icv) route. Twenty-four hours later, we measured P-gp and BCRP protein expression in isolated brain capillary by immunoblotting as well as by transport activityin vivoby measuring the unbound drug partitioning coefficient of the brain (Kp,uu,brain) of known efflux transporter substrates administered intravenously. Glial activation was measured by immunohistochemistry. The release of cytokines/chemokines (interleukins-1α, 1-β (IL-1β), -6 (IL-6), -10 (IL-10), monocyte chemoattractant protein (MCP-1/CCL2), fractalkine and tissue inhibitor of metalloproteinases-1 (TIMP-1)) were simultaneously measured in brain and serum samples using the Agilent Technology cytokine microarray.Results: We found that juvenile and adult BBBs exhibited similar P-gp and BCRP transport activities in the normal physiological conditions. However, long-term exposure of the juvenile brain to low-dose of ET-1 did not change BBB P-gp transport activity but tended to decrease BCRP transport activity in the juvenile brain, while a significant increase of the activity of both transporters was evidenced at the BBB in the adult brain. Moreover, juvenile and adult brain showed differences in their expression profiles of cytokines and chemokines mediated by ET-1.Conclusions: BBB transporter activity during neuroinflammation differs between the juvenile and adult brains. These findings emphasize the importance of considering differential P-gp and BCRP transport regulation mechanisms between adult and juvenile BBB in the context of neuroinflammation.

30 September 2016 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
ABAmélie Barthélémy
Amélie Barthélémy
AMAmandine Mouchard
Amandine Mouchard
MBMarc Bouji
Marc Bouji
KBKelly Blazy
Kelly Blazy
RPRenaud Puigsegur
Renaud Puigsegur
AVAnne-Sophie Villégier
Anne-Sophie Villégier

14 January 2010 in Psychopharmacology
Verified
Journal Article
Open access
PDF file
AVAnne-Sophie Villégier
Anne-Sophie Villégier
BGBrittney Gallager
Brittney Gallager
JHJon Heston
Jon Heston
JBJames D. Belluzzi
James D. Belluzzi
FLFrances M. Leslie
Frances M. Leslie
Rationale Epidemiological studies have demonstrated a comorbidity of smoking with depression and anxiety, particularly during adolescence. However, few animal studies have considered possible synergistic interactions between nicotine and other tobacco smoke constituents, such as monoamine oxidase (MAO) inhibitors, in the regulation of mood. Objectives The aim of the study was to test the hypothesis that nicotine combined with the irreversible MAO inhibitor, tranylcypromine, will differentially affect depression- and anxiety-related behaviors in adolescent and adult rats. Methods Nicotine (0, 0.05, 0.2 mg/kg, s.c.) and tranylcypromine (3 mg/kg, i.p.) were tested separately, or together, on male rats aged postnatal days 30 and 68, in three mood-related behavioral tests: forced swim test (FST), elevated plus maze (EPM), and open field. Results Nicotine (0.2 mg/kg) in adults significantly decreased floating time in the FST and increased time spent in the open arm of the EPM, with no change in locomotor activity. Tranylcypromine pretreatment combined with nicotine (0.2 mg/kg) significantly increased locomotor activity and time spent in the center of the open field. Whereas nicotine alone had no significant effect on adolescents, it significantly increased locomotor activity and decreased floating time in the FST when combined with tranylcypromine pretreatment. Conclusions There is an age-dependent effect of nicotine, alone and in combination with MAO inhibition, on mood-related behaviors. Whereas nicotine alone induces mood improvement in adults, it has no effect on adolescents. Nicotine combined with tranylcypromine has unique, age-dependent effects. Thus, experimental studies of smoking should consider both age and other tobacco constituents, such as MAO inhibitors, as critical factors.

1 March 2018 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
BLBérengère Laporte
Bérengère Laporte
Jérôme GAY-QUEHEILLARDJérôme GAY-QUEHEILLARD
Jérôme GAY-QUEHEILLARD
VBVeronique Bach
Veronique Bach
AVAnne-Sophie Villégier
Anne-Sophie Villégier

25 November 2019 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
MBMarc Bouji
Marc Bouji
ALAnthony Lecomte
Anthony Lecomte
CGChristelle Gamez
Christelle Gamez
KBKelly Blazy
Kelly Blazy
AVAnne-Sophie Villégier
Anne-Sophie Villégier
Background: Alzheimer’s disease (AD) is the most common type of neurodegenerative disease leading to dementia. Several studies suggested that mobile phone radiofrequency electromagnetic field (RF-EMF) exposures modified AD memory deficits in rodent models. Objective: Here we aimed to test the hypothesis that RF-EMF exposure may modify memory through corticosterone and oxidative stress in the Samaritan rat model of AD. Methods: Long-Evans male rats received intracerebroventricular infusion with ferrous sulphate, amyloid-beta 1-42 peptide, and buthionine-sufloximine (AD rats) or with vehicle (control rats). To mimic cell phone use, RF-EMF were exposed to the head for 1 month (5 days/week, in restraint). To look for hazard thresholds, high brain averaged specific absorption rates (BASAR) were tested: 1.5 W/Kg (15 min), 6 W/Kg (15 min), and 6 W/Kg (45 min). The sham group was in restraint for 45 min. Endpoints were spatial memory in the radial maze, plasmatic corticosterone, heme oxygenase-1 (HO1), and amyloid plaques. Results: Results indicated similar corticosterone levels but impaired memory performances and increased cerebral staining of thioflavine and of HO1 in the sham AD rats compared to the controls. A correlative increase of cortical HO1 staining was the only effect of RF-EMF in control rats. In AD rats, RF-EMF exposures induced a correlative increase of hippocampal HO1 staining and reduced corticosterone. Discussion: According to our data, neither AD nor control rats showed modified memory after RF-EMF exposures. Unlike control rats, AD rats showed higher hippocampal oxidative stress and reduced corticosterone with the higher BASAR. This data suggests more fragility related to neurodegenerative disease toward RF-EMF exposures.

12 November 2018 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
NONihal Ouadah
Nihal Ouadah
ALAnthony Lecomte
Anthony Lecomte
FRFranck Robidel
Franck Robidel
AOAnn Olsson
Ann Olsson
IDIsabelle Deltour
Isabelle Deltour
AVAnne-Sophie Villégier
Anne-Sophie Villégier